{"id":420208,"date":"2021-01-25T08:33:18","date_gmt":"2021-01-25T13:33:18","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=420208"},"modified":"2021-01-25T08:33:18","modified_gmt":"2021-01-25T13:33:18","slug":"medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/","title":{"rendered":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">TORONTO, CHICAGO and MONTREAL, Jan.  25, 2021  (GLOBE NEWSWIRE) &#8212; Medexus Pharmaceuticals Inc. (the \u201c<strong>Company<\/strong>\u201d or <strong>\u201cMedexus<\/strong>\u201d) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)<strong>\u00a0<\/strong>announced today that it has renewed and expanded its distribution agreement for NYDA<sup>\u00ae<\/sup>, a market leading treatment for head lice, through September 26, 2026. The agreement with G. Pohl-Boskamp GmbH &amp; Co KG\u00a0(&#8220;<strong>Pohl-Boskamp<\/strong>&#8220;) provides the Company with exclusive Canadian distribution rights for NYDA\u00ae and includes a commitment related to bringing new and innovative solutions to the Canadian market. The initial agreement with Pohl-Boskamp was signed in 2011 and the first extension was announced in June 2015.<\/p>\n<p align=\"justify\">Richard Labelle, Vice President Allergy, Pediatric and OTC Portfolios, commented, \u201cThe renewal and expansion of the agreement is the result of the solid relationship established over the years and based on the success achieved by NYDA<sup>\u00ae<\/sup> since its introduction in the Canadian market in 2012. Medexus is excited to extend this partnership that has resulted in a market leader in the category. We are currently working towards providing patients with new and improved offerings of this treatment.\u201d<\/p>\n<p align=\"justify\">\n        <strong>About Medexus<\/strong>\n      <\/p>\n<p align=\"justify\">Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform. The Company\u2019s vision is to provide the best healthcare products to healthcare professionals and patients, through our core values of Quality, Innovation, Customer Service and Teamwork. Medexus Pharmaceuticals is focused on the therapeutic areas of auto-immune disease, hematology and allergy. The Company\u2019s leading products are: Rasuvo\u2122 and Metoject\u00ae, a unique formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases; IXINITY\u00ae, an intravenous recombinant factor IX therapeutic for use in patients 12 years of age or older with Hemophilia B \u2013 a hereditary bleeding disorder characterized by a deficiency of clotting factor IX in the blood, which is necessary to control bleeding; and Rupall\u00ae, an innovative allergy medication with a unique mode of action.<\/p>\n<p align=\"justify\">\n        <strong>For more information, please contact:<\/strong>\n      <\/p>\n<p>Ken d\u2019Entremont, Chief Executive Officer<br \/>Medexus Pharmaceuticals Inc.<br \/>Tel.: 905-676-0003<br \/>E-mail:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Fp1pg8M7isrIcqXoleaaxivUz1KeEsw1b2E2guR2L1PnbUodn9YuiYzLDcYeY6O8Ao9dEVyuz2kkxNcx7jyetL6MnfZPcfEc90WSHt7g3d55ldX_t1Vkl56ZASWRQACT\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">ken.dentremont@medexus.com<\/a><\/p>\n<p>Roland Boivin, Chief Financial Officer<br \/>Medexus Pharmaceuticals Inc.<br \/>Tel.: 514-344-8765<br \/>E-mail:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2dYtCMR9FEZrcn1q5LcU66bgMA0gFfq2XkMvSTF-ipiivZzHtrbLlsn-MF_I-SWO9i9Pn-P8s6qpt9xjS21HygvXht1I8FjF3czc9JJEhKs=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">roland.boivin@medexus.com<\/a><\/p>\n<p>Investor Relations (U.S.):<br \/>Crescendo Communications, LLC<br \/>Tel: +1-212-671-1020<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LcgN9Y8U7D6rbWp9hDjcbekR2nhWpN6Ly_FalyNd1OyhmP8bar2Um6UV71yTcWKpe4FHTzWwEN0z_9UXrUT-TJkaVkCHsCbOWfHjG_BtPpE=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mdp@crescendo-ir.com<\/a><\/p>\n<p>Investor Relations (Canada):<br \/>Tina Byers<br \/>Adelaide Capital <br \/>Tel: 905-330-3275<br \/>E-mail:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jf6-2W0IPnECeuMSjUt6iLympZcGt8jrQ1huCVxICp4NegxeFs9BLFCc1amxDjtsb_8_v2XcLZhT3_goJY0H5Q==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">tina@adcap.ca<\/a><\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6bddfeb9-a00e-4548-a273-d11ad144c5b4\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>TORONTO, CHICAGO and MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Medexus Pharmaceuticals Inc. (the \u201cCompany\u201d or \u201cMedexus\u201d) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)\u00a0announced today that it has renewed and expanded its distribution agreement for NYDA\u00ae, a market leading treatment for head lice, through September 26, 2026. The agreement with G. Pohl-Boskamp GmbH &amp; Co KG\u00a0(&#8220;Pohl-Boskamp&#8220;) provides the Company with exclusive Canadian distribution rights for NYDA\u00ae and includes a commitment related to bringing new and innovative solutions to the Canadian market. The initial agreement with Pohl-Boskamp was signed in 2011 and the first extension was announced in June 2015. Richard Labelle, Vice President Allergy, Pediatric and OTC Portfolios, commented, \u201cThe renewal and expansion of the agreement is the result of the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-420208","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"TORONTO, CHICAGO and MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Medexus Pharmaceuticals Inc. (the \u201cCompany\u201d or \u201cMedexus\u201d) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)\u00a0announced today that it has renewed and expanded its distribution agreement for NYDA\u00ae, a market leading treatment for head lice, through September 26, 2026. The agreement with G. Pohl-Boskamp GmbH &amp; Co KG\u00a0(&#8220;Pohl-Boskamp&#8220;) provides the Company with exclusive Canadian distribution rights for NYDA\u00ae and includes a commitment related to bringing new and innovative solutions to the Canadian market. The initial agreement with Pohl-Boskamp was signed in 2011 and the first extension was announced in June 2015. Richard Labelle, Vice President Allergy, Pediatric and OTC Portfolios, commented, \u201cThe renewal and expansion of the agreement is the result of the &hellip; Continue reading &quot;Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-25T13:33:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae\",\"datePublished\":\"2021-01-25T13:33:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/\"},\"wordCount\":380,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/\",\"name\":\"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\",\"datePublished\":\"2021-01-25T13:33:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/","og_locale":"en_US","og_type":"article","og_title":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk","og_description":"TORONTO, CHICAGO and MONTREAL, Jan. 25, 2021 (GLOBE NEWSWIRE) &#8212; Medexus Pharmaceuticals Inc. (the \u201cCompany\u201d or \u201cMedexus\u201d) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731)\u00a0announced today that it has renewed and expanded its distribution agreement for NYDA\u00ae, a market leading treatment for head lice, through September 26, 2026. The agreement with G. Pohl-Boskamp GmbH &amp; Co KG\u00a0(&#8220;Pohl-Boskamp&#8220;) provides the Company with exclusive Canadian distribution rights for NYDA\u00ae and includes a commitment related to bringing new and innovative solutions to the Canadian market. The initial agreement with Pohl-Boskamp was signed in 2011 and the first extension was announced in June 2015. Richard Labelle, Vice President Allergy, Pediatric and OTC Portfolios, commented, \u201cThe renewal and expansion of the agreement is the result of the &hellip; Continue reading \"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-25T13:33:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae","datePublished":"2021-01-25T13:33:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/"},"wordCount":380,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/","name":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=","datePublished":"2021-01-25T13:33:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODE0MDU1MiMzOTQxMTAyIzIxMjU3ODQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/medexus-announces-renewal-and-expansion-of-canadian-distribution-agreement-for-nyda\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Medexus Announces Renewal and Expansion of Canadian Distribution Agreement for NYDA\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=420208"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/420208\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=420208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=420208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=420208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}